The hazard ratios of CS subtypes were similar to the tumor stage, which is often used to evaluate the patient’s prognosis in the clinic and were significantly superior to those of AFP, albumin (ALB) and PT (P < 0.05) (Figure 2D). This evidence concerns the gene ALB and neoplasm.